A High Frequency Spinal Cord Stimulation PET-CT Scan Study
NCT ID: NCT03716557
Last Updated: 2025-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2018-02-09
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Feasibility Study to Investigate the Dynamic Brain Imaging in Patients Following SCS- DRG
NCT04508127
Modulating Neuropathic Pain With Transcranial Direct Current Stimulation
NCT04581525
Thalamic-Burst-DBS for Neuropathic Pain
NCT05204472
Investigation of the Duration of Low-intensity Focused Ultrasound
NCT05147103
Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients
NCT01948050
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
20 patients who are deemed suitable for SCS as part of NICE guidelines 159 pathway will be recruited for the study. All patients will have a baseline PET-CT scan and undergo first stage of SCS where they will be offered tonic 40Hz settings as part of trial stimulation. If successful (\>50% improvement in pain scores) patients will be offered second stage and continue to receive 40Hz stimulation for 4 weeks. After a second PET-CT scan they are randomised to receive either 4000Hz or 10000Hz stimulation for 4 more weeks, then cross-over treatment for another 4 weeks. PET-CT scans will be performed between each level of stimulation and at the end of the study (4 in total).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spinal Cord Stimulation 4000Hz
Patients will trial Spinal Cord Stimulation 4000Hz for 4 weeks. PET/CT scan will be conducted at the end of this period.
Spinal Cord Stimulation 4000Hz
Differential programming of the Boston Scientific Precision™ Plus Spinal Cord Stimulator System
Spinal Cord Stimulation 10000Hz
Patients will trial Spinal Cord Stimulation 10,000Hz for 4 weeks. PET/CT scan will be conducted at the end of this period.
Spinal Cord Stimulation 10000Hz
Differential programming of the Boston Scientific Precision™ Plus Spinal Cord Stimulator System
Spinal Cord Stimulation 40Hz
Patients will trial Spinal Cord Stimulation 10,000Hz for 4 weeks. PET/CT scan will be conducted at the end of this period.
Spinal Cord Stimulation 40Hz
Differential programming of the Boston Scientific Precision™ Plus Spinal Cord Stimulator System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spinal Cord Stimulation 4000Hz
Differential programming of the Boston Scientific Precision™ Plus Spinal Cord Stimulator System
Spinal Cord Stimulation 10000Hz
Differential programming of the Boston Scientific Precision™ Plus Spinal Cord Stimulator System
Spinal Cord Stimulation 40Hz
Differential programming of the Boston Scientific Precision™ Plus Spinal Cord Stimulator System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients between 18 and 75 years of age.
* Patients who have given their written informed consent.
* Female patients of childbearing potential must be using adequate contraception (i.e. using oral or IM contraception or an IUCD) and must have a negative urine pregnancy test.
* Patients must be able to communicate in English in order to complete validated questionnaires written in English only.
Exclusion Criteria
* Patients known to have a condition that in the investigator's judgement precludes participation in the study.
* Patients who have received an investigational drug or have used an investigational device in the 30 days preceding study entry.
* Patients unable to comply with the study assessments and to complete the questionnaires.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Barts & The London NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vivek Mehta, MD
Role: PRINCIPAL_INVESTIGATOR
Barts & The London NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barts Health NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Poply K, Haroon A, Ganeshan B, Nikolic S, Sharma S, Ahmad A, Ellamushi H, Parsai A, Mehta V. Dynamic Brain Imaging Response to Spinal Cord Stimulation Differential Frequencies DiFY SCS-PET Clinical Trial. Neuromodulation. 2023 Jul;26(5):988-998. doi: 10.1016/j.neurom.2022.07.012. Epub 2022 Sep 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
011768
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.